Andreas Flörsheimer

569 total citations
12 papers, 409 citations indexed

About

Andreas Flörsheimer is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Andreas Flörsheimer has authored 12 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Andreas Flörsheimer's work include Chemical Synthesis and Analysis (4 papers), Cancer Treatment and Pharmacology (4 papers) and Synthetic Organic Chemistry Methods (4 papers). Andreas Flörsheimer is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Cancer Treatment and Pharmacology (4 papers) and Synthetic Organic Chemistry Methods (4 papers). Andreas Flörsheimer collaborates with scholars based in Switzerland, Germany and France. Andreas Flörsheimer's co-authors include Karl‐Heinz Altmann, Marcel J. J. Blommers, François Hamy, Thomas Klimkait, Vincent Brondani, Wilhelm Stark, Guido Bold, Giorgio Caravatti, B. Kamber and B. Riniker and has published in prestigious journals such as Biochemistry, Biochemical and Biophysical Research Communications and Annals of the New York Academy of Sciences.

In The Last Decade

Andreas Flörsheimer

11 papers receiving 391 citations

Peers

Countries citing papers authored by Andreas Flörsheimer

Since Specialization

Citations

This map shows the geographic impact of Andreas Flörsheimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Flörsheimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Flörsheimer more than expected).

Fields of papers citing papers by Andreas Flörsheimer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Flörsheimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Flörsheimer. The network helps show where Andreas Flörsheimer may publish in the future.

Co-authorship network of co-authors of Andreas Flörsheimer

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Flörsheimer. A scholar is included among the top collaborators of Andreas Flörsheimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Flörsheimer. Andreas Flörsheimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Antileukemic Effects of Novel First- and Second-Generation FLT3 Inhibitors: Structure-Affinity Comparison 2010 ·Genes & Cancer ·(unknown), Johannes Roesel, Pascal Furet, Guido Bold, Patricia Imbach, Andreas Flörsheimer, Giorgio Caravatti, Jie Jiang, Paul W. Manley, Arghya Ray, James D. Griffin	33
2	The Natural Products Epothilones A and B as Lead Structures for Anticancer Drug Discovery: Chemistry, Biology, and SAR Studies 2004 ·Progress in medicinal chemistry ·Karl‐Heinz Altmann, Andreas Flörsheimer, Terence O’Reilly, Markus Wartmann	6
3	Second-Site NMR Screening and Linker Design 2003 ·Current Topics in Medicinal Chemistry ·Wolfgang Jahnke, Andreas Flörsheimer, Marcel J. J. Blommers, C. Paris, Jutta Heim, Carlo M. Nalin, Lawrence Perez	47
4	The Total Synthesis and Biological Assessment of trans-Epothilone A 2002 ·Helvetica Chimica Acta ·Karl‐Heinz Altmann, Guido Bold, Giorgio Caravatti, (unknown), Andreas Flörsheimer, Alfred Schmidt, Grety Rihs, Markus Wartmann	52
5	Epothilones and their analogues - a new class of promising microtubule inhibitors 2001 ·Expert Opinion on Therapeutic Patents ·Andreas Flörsheimer, Karl‐Heinz Altmann	20
6	An ARE-Selective DNA Minor Groove Binder from a Combinatorial Approach 2000 ·Biochemical and Biophysical Research Communications ·François Hamy, (unknown), Andreas Flörsheimer, Christian Bailly	7
7	Epothilones and Their Analogs – Potential New Weapons in the Fight Against Cancer 2000 ·CHIMIA International Journal for Chemistry ·Karl‐Heinz Altmann, Guido Bold, Giorgio Caravatti, Nicole End, Andreas Flörsheimer, Vito Guagnano, Terence O’Reilly, Markus Wartmann	25
8	A New Class of HIV-1 Tat Antagonist Acting through Tat−TAR Inhibition 1998 ·Biochemistry ·François Hamy, Vincent Brondani, Andreas Flörsheimer, Wilhelm Stark, Marcel J. J. Blommers, Thomas Klimkait	121
9	A General Strategy for the Synthesis of Large Peptides: r1~he Combined Solid-Phase and Solution Approach. 1993 ·Tetrahedron ·B. Riniker, Andreas Flörsheimer, Heinz Fretz, Peter Sieber, B. Kamber	60
10	Protecting Groups for the Enzymatic Peptide Synthesis^a 1990 ·Annals of the New York Academy of Sciences ·Andreas Flörsheimer, Alexander Schwarz, (unknown), Matthias Kittelmann, G. Herrmann, M.‐R. Kula, Christian Wandrey	0
11	Continuous production of kyotorphin 1989 ·Biotechnology and Bioengineering ·Andreas Flörsheimer, Maria‐Regina Kula, (unknown), Christian Wandrey	16
12	Sequence dependence of secondary‐structure formation part IV Helix‐forming potential of amphiphilic oligopeptides containing aib residues 1986 ·Helvetica Chimica Acta ·Manfred Mutter, Karl‐Heinz Altmann, Andreas Flörsheimer, (unknown)	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact